Wound Management News

Patients with intermediate junctional epidermolysis bullosa are at risk for kidney-urinary tract manifestations, according to a study.

Nonabsorbable sutures or tissue adhesives used in combination with surgical strips and liquid adhesives are safe and effective means to minimizing hyperpigmentation in skin of color following Mohs micrographic surgery, according to a study.

Patients with dystrophic epidermolysis bullosa had positive phase 3 results with Vyjuvek treatment, Krystal Biotech announced in a press release.

The FDA has denied a New Drug Application for oleogel-S10 for the treatment of the cutaneous manifestations of dystrophic and junctional epidermolysis bullosa, Amryt Pharma announced in a press release.

The addition of a tumor necrosis factor inhibitor to steroid therapy reduced acute stage disease duration and hospital stay in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis, according to a study.

Enrollment in a trial to evaluate the Recell system for soft-tissue reconstruction has been completed, according to a press release from Avita.

Implicit racial bias could play a part in antibiotics prescribed for skin and soft tissue infections, according to a research letter published in JAMA Network Open.

Acute generalized exanthematous pustulosis is usually triggered by new antimicrobials and is often improved with the discontinuation of the causing drug, according to a study.

Patients who underwent complex reconstruction following Mohs micrographic surgery were more satisfied with their appearance and scars in the long-term, according to a presentation.

Multiple debridements and the use of flaps are associated with longer closure times on complex infectious wounds, according to a study presented at the American Society for Dermatologic Surgery virtual meeting.